Go Pro

First Trust NYSE Arca Biotechnology Index Fund (FBT) Chart & Stock Price History

First Trust NYSE Arca Biotechnology Index Fund logo
$273.79 +0.32 (+0.12%)
As of 04:10 PM Eastern

First Trust NYSE Arca Biotechnology Index Fund Stock Price Performance

The First Trust NYSE Arca Biotechnology Index Fund (FBT) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has increased 56.28%, with a year-to-date return of 32.57%. In the past month, the fund has increased 11.52%, reflecting recent market activity.

As of the latest close, First Trust NYSE Arca Biotechnology Index Fund traded at $273.79 with a market cap of $3.03 billion and volume of 18,957 shares. Five years ago, the fund traded at $175.33, representing a 56.16% increase over that period. At the time, it had a market cap of $1.94 billion and a volume of 19,164 shares.

Receive FBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for First Trust NYSE Arca Biotechnology Index Fund and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+2.56%
1 Month
Performance
+11.52%
3 Month
Performance
+23.80%
Year-To-Date
Performance
+32.57%
1 Year
Performance
+56.28%
5 Year
Performance
+56.16%

FBT Stock Chart for Thursday, September, 3, 2026

First Trust NYSE Arca Biotechnology Index Fund Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/03/2026$273.47$273.79
+0.12%
$274.99$271.4818,957 shs$3.03 billion
09/02/2026$267.84$273.47
+2.10%
$273.87$267.3739,007 shs$3.02 billion
09/01/2026$267.15$267.84
+0.26%
$268.38$266.1525,048 shs$2.96 billion
08/31/2026$266.95$267.15
+0.07%
$267.99$263.1742,382 shs$2.95 billion
08/28/2026$273.91$266.95
-2.54%
$272.37$266.9532,817 shs$2.95 billion
08/27/2026$272.07$273.91
+0.68%
$274.81$271.2626,467 shs$3.03 billion
08/26/2026$272.38$272.07
-0.11%
$273.14$270.7861,725 shs$3.01 billion
08/25/2026$268.96$272.38
+1.27%
$272.91$270.2566,206 shs$3.01 billion
08/24/2026$270.95$268.96
-0.73%
$269.70$267.28189,578 shs$2.97 billion
08/21/2026$268.13$270.95
+1.05%
$272.80$269.0837,988 shs$2.99 billion
08/20/2026$271.87$268.13
-1.38%
$271.13$267.8537,472 shs$2.96 billion
08/19/2026$260.74$271.87
+4.27%
$271.87$265.8385,519 shs$3.00 billion
08/18/2026$259.63$260.74
+0.43%
$261.74$260.0322,546 shs$2.88 billion
08/17/2026$255.42$259.63
+1.65%
$259.73$255.4039,577 shs$2.87 billion
08/14/2026$256.07$255.42
-0.25%
$255.58$253.3141,294 shs$2.82 billion
08/13/2026$258.95$256.07
-1.11%
$260.46$256.0732,401 shs$2.83 billion
08/12/2026$258.65$258.95
+0.12%
$260.04$256.4730,553 shs$2.86 billion
08/11/2026$258.53$258.65
+0.05%
$260.25$258.4823,374 shs$2.86 billion
08/10/2026$255.93$258.53
+1.02%
$258.53$255.8118,469 shs$2.86 billion
08/07/2026$248.24$255.93
+3.10%
$255.93$251.9432,284 shs$2.83 billion
08/06/2026$249.00$248.24
-0.31%
$249.52$246.7424,487 shs$2.74 billion
08/05/2026$247.12$249.00
+0.76%
$250.62$248.1446,034 shs$2.75 billion
08/04/2026$245.50$247.12
+0.66%
$247.13$243.6140,142 shs$2.73 billion
08/03/2026$245.06$245.50
+0.18%
$246.04$242.8632,327 shs$2.71 billion

This page (NYSEARCA:FBT) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners